Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page revision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's backend or formatting. No changes to the study details or data are introduced.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a minor maintenance release with no changes to the study details or user-facing content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedVersion 3.5.0 was added and version 3.4.3 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded site revision notice: Revision: v3.4.2. Removed the earlier funding-lapse notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a global notice about a lapse in government funding and NIH Clinical Center operations, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.